HAYW Hayward Holdings, Inc. Insider Trading

CEO Holleran sells 170,000 shares ($2.9M) via scheduled 10b5-1 plan as stock gains 21.1% in 30 days

Kevin Holleran, President and CEO of Hayward Holdings, executed 2 separate sales totaling 170,000 shares (170.0K shares) for $2,927,594.00 ($2.9M) on June 30 and July 1, 2026, at a blended average price of $17.22. The sales were executed under a pre-arranged 10b5-1 trading plan adopted on 2025-08-18, making them scheduled rather than discretionary. Post-transaction, Holleran retains 701,234 shares (701.2K shares) of non-derivative holdings, and maintains derivative holdings of 4,180,472 shares across two stock option instruments, indicating his economic exposure remains substantial. The timing of these sales coincides with strong near-term price momentum (30-day change: +21.1%, 90-day change: +26.8%), though the pre-arranged nature of the plan means the execution dates were determined in advance rather than reflecting tactical market timing. At the same ticker, Holleran's prior 5 sales show mixed outcomes: two of his three completed 90-day measurements returned positive (April 2026: +29.0%, March 2026: -10.3%), while his most recent sales in June and May 2026 remain too recent for 90-day assessment.

CEO Kevin Holleran sold 52,389 shares of HAYW at $13.79 (now $13.98) under 10b5-1 plan; retains 701,234 shares plus 2,200,236 option shares

Kevin Holleran, President and CEO, executed a scheduled sale of 52,389 shares on 2026-06-01 under a pre-arranged 10b5-1 trading plan adopted on 2025-08-18, reducing his non-derivative holdings from 753,623 to 701,234 shares. The stock was trading $13.98 at current prices versus the $13.79 transaction price, and is -21.2% from its 52-week high of $17.73, reflecting material weakness year-to-date. His prior five sales at HAYW show a mixed record: three produced negative 30-day returns (-14.2%, -3.9%, -3.4%), one produced +12.1%, and one produced +1.4%, indicating inconsistent execution relative to price reversals. Because this trade is scheduled under a 10b5-1 plan rather than discretionary, it does not reflect a timing decision by the insider. Critically, Holleran retains substantial derivative holdings of 2,200,236 stock options, meaning his full economic position in the company remains significant and unchanged by this share reduction.

CEO Kevin Holleran exercised options for 52K shares then sold them the same day at 10x the exercise price; 29th open-market sale in 3 years.

Kevin Holleran, Hayward Holdings' President and CEO, exercised options on 52,389 shares at $1.40 and immediately sold the entire block at $14.5744 on the same day—a characteristic same-day exercise-and-sell pattern typical of option vesting mechanics rather than a statement about conviction. This is the 29th open-market sale Holleran has executed in the past three years, with zero open-market purchases during that same period; he has been exclusively a seller at the open market. The stock is currently trading below its 52-week high and has declined over the past quarter, but without measurable outcome data from his five most recent sales at this ticker—all too recent to evaluate—the timing pattern of his prior exits at Hayward cannot yet be assessed. The company itself remains profitable with steady revenue growth and trades at a reasonable valuation multiple, suggesting fundamental stability despite the stock's recent price weakness.

SVP and CLO Susan Canning buys 2,242 shares of HAYW as stock recovers from recent pullback, signaling management confidence.

Susan Canning, the Senior Vice President and Chief Legal Officer, made an open-market purchase of shares at a time when the stock is trading well below its highs but has recently recovered from a three-month decline. As a C-suite executive with direct operational visibility into the company, her willingness to deploy personal capital sends a meaningful signal of confidence in the business and its valuation. Hayward is a profitable, growing company with solid fundamentals, and Canning's purchase suggests the leadership team believes the current pullback represents an attractive entry point rather than a warning sign. This kind of insider buying by core management — particularly from a legal and governance officer who would be sensitive to compliance risks — carries credibility precisely because such executives rarely make speculative trades; when they do buy, it typically reflects genuine conviction that the market is undervaluing the stock at these levels.

HAYW CEO Kevin Holleran sold 52,389 shares at $13.42 on 2026-04-01, reducing stake by 7.0% to 701,234 shares.

CEO Kevin Holleran executed a discretionary sale of 52,389 shares at $13.42, representing a 7.0% reduction in his post-transaction holdings to 701,234 shares. The stock has declined 22.3% from its 52-week high and 14.1% over the past 30 days, with Holleran's prior trades at HAYW showing mixed timing: his two most recent 90-day outcomes were both negative (−4.8% and −3.6%), suggesting alignment with downturns. However, his cross-ticker track record shows an average 90-day return of +4.5% following sales across 20 open-market transactions, indicating prior sells have generally preceded gains elsewhere. The company's fundamentals remain solid with $244.3M quarterly revenue and +6.7% annual growth, but the recent price deterioration and CEO equity reduction warrant observation of whether this signals confidence in a near-term recovery or reflects concern about near-term conditions.

HAYW CEO Kevin Holleran sold 52,389 shares ($824,021.34) on 2026-03-02; stock down 10.0% from 52-week high.

Kevin Holleran, President and CEO of Hayward Holdings, sold 52,389 shares at $15.73 on 2026-03-02, reducing his holdings from 772,542 to 720,153 shares. The sale occurs with HAYW trading 10.0% below its 52-week high of $17.22 and down 3.7% over the prior 30 days, indicating a period of stock softness. Holleran's cross-ticker track record shows 35.29% well-timed selling rate across 20 prior sales with an average 90-day return of +4.9%, suggesting his sell timing has been inconsistent. At the same ticker, his 5 prior trades at HAYW show 1 of 2 measurable 90-day outcomes was well-timed (the 2025-11-03 sale preceded a -3.6% 90-day decline), while the 2025-10-01 sale resulted in a +3.9% 90-day gain—a mixed pattern specific to this security. The company maintains solid fundamentals with $244.3M quarterly revenue, $24.0M net income, and 6.7% annual growth, though the elevated P/E of 19.62 relative to sector averages merits monitoring.

HAYW: CEO Holleran sold 52,389 shares ($840.7K) at $16.05 on 2026-02-02, reducing stake -7.8% to 623.5K shares

Kevin Holleran, President and CEO of Hayward Holdings, executed a substantial open-market sale of 52,389 shares at $16.05, reducing his holdings from 675,929 to 623,540 shares and generating $840,743.91 in proceeds. The sale occurred near the 52-week high of $17.22, with the current price of $16.21 trading 5.9% below that high. Examining Holleran's prior trades at Hayward across five recent transactions, his sell timing has been inconsistent: his most recent sale on 2026-01-05 shows +1.4% in the 30-day window, but earlier sells in November and December 2025 resulted in negative 30-day and 90-day returns, and only 1 of 3 prior sells with measurable 90-day outcomes were well-timed (33% well-timed rate at this ticker). This sale represents standard portfolio diversification for a principal shareholder, warranting routine investor monitoring alongside his continued significant beneficial ownership.

HAYW President/CEO Kevin Holleran sold 52,390 shares at $15.99 on 2026-01-05; holds 623,540 post-sale.

Kevin Holleran sold 52,390 shares (-7.8% vs pre-transaction holdings) for $837,899.47 at $15.99, near his recent five-trade pattern on this ticker where he has consistently sold over the past five months. At this ticker specifically, his 5 prior trades show 0 of 3 measurable 90-day outcomes were well-timed (stock rose after 2 of the 3 measurable sales, meaning he sold before gains). His cross-ticker track record across 20 prior sells shows an average 90-day return of +4.9% (poorly timed: stock rose after his sales), with a 33.33% well-timed rate. The current price of $15.58 is -9.5% from the 52-week high of $17.22 and -1.7% lower than 30 days ago, while the stock is +2.1% over 90 days; this recent sale occurred at $15.99, slightly above current levels. The company's fundamentals remain solid with revenue of $244,336,000.00, net income of $24,028,000.00, and +6.0% annual revenue growth, though the P/E of 24.34 reflects a moderately valued position.

CEO Kevin Holleran sold 60,571 shares of HAYW at $16.13 for $976,889.09, reducing holdings by 8.9%.

Kevin Holleran, President and CEO, sold 60,571 shares (60.6K shares) on 2025-12-05 at $16.13 per share, reducing his holdings from 684,111 to 623,540 shares. The sale occurred near the 52-week high of $17.22 (-9.1% from peak), and the company's fundamentals remain solid with $244,336,000.00 in quarterly revenue, $24,028,000.00 in net income, and 6.0% annual revenue growth. However, his prior trades at HAYW show mixed timing outcomes: only 3 of 5 prior measurable sells have 90-day results available, and 0 of those 3 were well-timed (all showed positive 90-day returns, meaning the stock rose after he sold). His broader cross-ticker track record shows a 38.89% well-timed rate on 20 prior sells, which is moderately above a random baseline, but this current ticker exhibits weaker timing discipline. The sale size represents a meaningful reduction in an already-substantial stake, warranting investor attention to whether this reflects portfolio management or a shift in confidence relative to company trajectory.

Holleran (CEO) sold 60,571 shares of HAYW for $1.0M at $16.74 on 2025-11-03; price now $16.19.

Kevin Holleran, President and CEO, sold 60,571 shares (60.6K shares) on 2025-11-03 for $1,013,716.26 ($1.0M), reducing holdings from 684,111 to 623,540 shares (-8.9%). The sale occurred at $16.74, only -6.0% from the 52-week high of $17.22. At his prior HAYW sales, Holleran's 90-day timing record is mixed: of 3 prior measurable 90-day outcomes, 0 were well-timed (stock rose in all three cases), though his most recent HAYW sale on 2025-10-01 showed +11.9% 30-day upside and his June 2025 sale eventually yielded +13.7% at the 90-day mark. His cross-ticker track record shows a 44.44% well-timed rate on 20 prior sells—below 50%—with average 90-day returns of +3.0%, suggesting his sales have not systematically preceded declines. The company fundamentals are solid: revenue of $244.3M, net income of $24.0M, +6.0% annual growth, and a P/E of 25.30. This sale does not align with a clear pattern of prescient exit timing, and the stock has recovered modestly since the transaction date (+4.9% in 30 days).